Influenza A virus nucleoprotein derived from <it>Escherichia coli</it> or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice
<p>Abstract</p> <p>Background</p> <p>Immunity to conserved viral antigens is an attractive approach to develop a universal vaccine against epidemic and pandemic influenza. A nucleoprotein (NP)-based vaccine has been explored and preliminary studies have shown promise. H...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-12-01
|
| Series: | Virology Journal |
| Online Access: | http://www.virologyj.com/content/9/1/322 |